openPR Logo
Press release

Investigation announced for Investors in Ameris Bancorp (NASDAQ: ABCB)

12-12-2019 03:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Ameris Bancorp (NASDAQ: ABCB) shares over potential securities laws violations by Ameris Bancorp

An investigation for investors in Ameris Bancorp (NASDAQ: ABCB) shares over potential securities laws violations by Ameris Bancorp

Ameris Bancorp (NASDAQ: ABCB) is under investigation concerning potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Ameris Bancorp (NASDAQ: ABCB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Ameris Bancorp regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Moultire, GA based Ameris Bancorp operates as the bank holding company for Ameris Bank that provides banking services to retail and commercial customers primarily in Georgia, Alabama, Florida, and South Carolina. Ameris Bancorp reported that its annual Total Revenue rose from $364.58 million in 2017 to $461.80 million in 2018 and that its Net Income increased from $73.54 million in 2017 to $121.02 million in 2018.

On November 21, 2019, Ameris Bancorp revealed that the Company had received a subpoena from the U.S. Securities and Exchange Commission requesting documents and materials related to the purchase of U.S. Premium Finance and the sale of certain loans to CEBV LLC. In addition to the SEC subpoena, Ameris Bancorp's subsidiary, Ameris Bank, received a grand jury subpoena from the U.S. Attorney's Office for the Northern District of Georgia.

Shares of Ameris Bancorp (NASDAQ: ABCB) closed on December 11, 2019, at $43.24 per share.

Those who purchased shares of Ameris Bancorp (NASDAQ: ABCB) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Ameris Bancorp (NASDAQ: ABCB) here

News-ID: 1878318 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Ameris

Brilliant Epoxy Floors Completes New 47,224 Sq. Ft. Hangar Installation at Scott …
Image: https://www.globalnewslines.com/uploads/2025/07/1752112311.jpg The multi-hangar project features high-performance epoxy flooring tailored for demanding aviation use at the active airport Brilliant Epoxy Floors has completed the full flooring installation [https://www.brilliantaz.com/solutions] across all four hangars of Scottsdale Airpark's newest development. The 47,224-square-foot project-developed by Ameris Construction-includes a mix of large-format hangar bays and modern office space designed to support private and commercial aviation operations. The development includes Hangar 1, a 13,352-square-foot aviation hangar paired with a
Get Cheap 2025 Volbeat Tickets for All Shows with Promo Code CITY10 at CapitalCi …
Save big on 2025 Volbeat concert tickets at CapitalCityTickets.com! Use promo code CITY10 to get 10% off all seats, from front row to upper levels. Tickets are on sale now for all shows nationwide. Don't miss your chance to see Volbeat live-shop early, save more, and secure your spot for this must-see tour event today! Are you ready to rock out with Volbeat in 2025? The Danish metal band known for
How to Buy Cheap 2025 Mumford & Sons Tickets with Promo Code CITY10 at CapitalCi …
Save big on 2025 Mumford & Sons tickets at CapitalCityTickets.com! Use promo code CITY10 to get 10% off all seating levels for every show nationwide. Whether you want front-row seats or budget-friendly options, find the perfect tickets easily online. Don't miss out-secure your spot for the Mumford & Sons 2025 tour today and enjoy exclusive savings! Are you a fan of Mumford & Sons and planning to catch their 2025 tour?
Bio-Based Adipic Acid Market Analysis By Top Keyplayers - Verdezyne, DSM, BioAme …
The "Bio-Based Adipic Acid Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Bio-Based Adipic Acid Market, 2024-2031 Verified Market Research's most recent report, "Bio-Based Adipic Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Clinical Trial Market 2022 : Size, Growth Opportunities, Current Trends, Forecas …
The study report on Clinical Trial states the strategic and specialized needs of enterprises and companies. The Clinical Trial research report performs as an ideal window into the market, explaining market segmentation, classification, industries, market dynamics, and participation. Here, the intense competition is examined in terms of product offerings, approaches, and career outlook of the market's major players. In addition, the research provides practical market statistics and information about the
Global Bio-Based Adipic Acid Market 2019 - Ameris, Aemethis, Genomatica, Rennovi …
Adipic acid is the most widely used dicarboxylic acid from the industrial perspective. Adipic acid is mainly used for the production of nylon which finds its application in composite materials which are used in manufacturing automobile components. Scope of the Report: This report focuses on the Bio-Based Adipic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on